Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 161

1.

Re-treatment for severe hepatitis flare in HBeAg-negative chronic hepatitis B: An appraisal with combined HBsAg/ALT kinetics.

Chien RN, Liaw YF.

J Viral Hepat. 2019 Dec 23. doi: 10.1111/jvh.13253. [Epub ahead of print]

PMID:
31868280
2.

New Scoring Method to Predict Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis C after Pegylated Interferon and Ribavirin Therapy.

Hu CC, Weng CH, Hua MC, Chang PH, Lin CL, Chen YT, Chien CH, Lin ST, Chien RN.

J Interferon Cytokine Res. 2019 Dec 3. doi: 10.1089/jir.2019.0103. [Epub ahead of print]

PMID:
31800346
3.

Impact of mixed cryoglobulinemia on patients with spontaneous hepatitis C virus clearance: A 13-year prospective cohort study.

Lee KC, Cheng YT, Lin CY, Kuo CJ, Chien RN, Yeh CT, Chang ML.

Eur J Clin Invest. 2020 Jan;50(1):e13189. doi: 10.1111/eci.13189. Epub 2019 Dec 26.

PMID:
31782138
4.

Telbivudine on IgG-associated hypergammaglobulinemia and TGF-β1 hyperactivity in hepatitis B virus-related liver cirrhosis.

Ho CH, Chang TT, Chien RN.

PLoS One. 2019 Nov 26;14(11):e0225482. doi: 10.1371/journal.pone.0225482. eCollection 2019.

5.

The Defective Allele of Aldehyde Dehydrogenase 2 Gene is Associated with Favorable Postoperative Prognosis in Hepatocellular Carcinoma.

Huang PH, Hu CC, Chien CH, Chen LW, Chien RN, Lin YS, Chao M, Lin CL, Yeh CT.

J Cancer. 2019 Oct 3;10(23):5735-5743. doi: 10.7150/jca.33221. eCollection 2019.

6.

A GALNT14 rs9679162 genotype-guided therapeutic strategy for advanced hepatocellular carcinoma: systemic or hepatic arterial infusion chemotherapy.

Lin CC, Hsu CW, Chen YC, Chang ML, Liang KH, Lai MW, Lin CL, Chien RN, Lin KH, Yeh CT.

Pharmacogenomics J. 2019 Oct 14. doi: 10.1038/s41397-019-0106-0. [Epub ahead of print]

PMID:
31611591
7.

Effects of sodium-glucose co-transporter-2 inhibitors on serum alanine aminotransferase levels in people with type 2 diabetes: A multi-institutional cohort study.

Shao SC, Chang KC, Chien RN, Lin SJ, Hung MJ, Chan YY, Kao Yang YH, Lai EC.

Diabetes Obes Metab. 2020 Jan;22(1):128-134. doi: 10.1111/dom.13875. Epub 2019 Oct 10.

PMID:
31486260
8.

Decreasing seroprevalence of anti-hepatitis D virus antibodies in the antiviral era with inverse association with hepatitis B virus DNA, Taiwan, 2006 to 2019.

Lee KC, Lin CL, Hsu CW, Chang ML, Chen YC, Lin WR, Lai MW, Lin KH, Chao M, Chien RN, Yeh CT.

J Med Virol. 2020 Jan;92(1):124-127. doi: 10.1002/jmv.25582. Epub 2019 Sep 4.

PMID:
31469172
9.

Evolution of renal function under direct-acting antivirals treatment for chronic hepatitis C: A real-world experience.

Tsai MC, Lin CY, Hung CH, Lu SN, Tung SY, Chien RN, Lin CL, Wang JH, Chien-Hung C, Chang KC, Hu TH, Sheen IS.

J Viral Hepat. 2019 Dec;26(12):1404-1412. doi: 10.1111/jvh.13193. Epub 2019 Oct 7.

PMID:
31433885
10.

Low vitamin D level was associated with metabolic syndrome and high leptin level in subjects with nonalcoholic fatty liver disease: a community-based study.

Chen LW, Chien CH, Kuo SF, Yu CY, Lin CL, Chien RN.

BMC Gastroenterol. 2019 Jul 16;19(1):126. doi: 10.1186/s12876-019-1040-y.

11.

Letter: contraindicated drug-drug interactions before and after initiation of direct-acting anti-viral agents in chronic hepatitis C patients in Taiwan.

Shao SC, Lai EC, Chang KC, Chan YY, Chen HY, Chien RN.

Aliment Pharmacol Ther. 2019 Jul;50(1):113-115. doi: 10.1111/apt.15303. No abstract available.

PMID:
31184385
12.

The extrahepatic events of Asian patients with primary biliary cholangitis: A 30-year cohort study.

Lin CY, Cheng YT, Chang ML, Chien RN.

Sci Rep. 2019 May 20;9(1):7577. doi: 10.1038/s41598-019-44081-x.

13.
14.

A community-based study on the application of fatty liver index in screening subjects with nonalcoholic fatty liver disease.

Chen LW, Huang PR, Chien CH, Lin CL, Chien RN.

J Formos Med Assoc. 2020 Jan;119(1 Pt 1):173-181. doi: 10.1016/j.jfma.2019.03.016. Epub 2019 Apr 11.

15.

An Open-Label, Randomized, Active-Controlled Trial of 8 Versus 12 Weeks of Elbasvir/Grazoprevir for Treatment-Naive Patients With Chronic Hepatitis C Genotype 1b Infection and Mild Fibrosis (EGALITE Study): Impact of Baseline Viral Loads and NS5A Resistance-Associated Substitutions.

Huang CF, Hung CH, Cheng PN, Bair MJ, Huang YH, Kao JH, Hsu SJ, Lee PL, Chen JJ, Chien RN, Peng CY, Lin CY, Hsieh TY, Cheng CH, Dai CY, Huang JF, Chuang WL, Yu ML.

J Infect Dis. 2019 Jul 19;220(4):557-566. doi: 10.1093/infdis/jiz154.

PMID:
30957170
16.

Is there a sex difference in postoperative prognosis of hepatocellular carcinoma?

Lai MW, Chu YD, Lin CL, Chien RN, Yeh TS, Pan TL, Ke PY, Lin KH, Yeh CT.

BMC Cancer. 2019 Mar 20;19(1):250. doi: 10.1186/s12885-019-5453-3.

17.

Diabetes poses a higher risk of hepatocellular carcinoma and mortality in patients with chronic hepatitis B: A population-based cohort study.

Shyu YC, Huang TS, Chien CH, Yeh CT, Lin CL, Chien RN.

J Viral Hepat. 2019 Jun;26(6):718-726. doi: 10.1111/jvh.13077. Epub 2019 Mar 5.

PMID:
30739359
18.

The Chang Gung Research Database-A multi-institutional electronic medical records database for real-world epidemiological studies in Taiwan.

Shao SC, Chan YY, Kao Yang YH, Lin SJ, Hung MJ, Chien RN, Lai CC, Lai EC.

Pharmacoepidemiol Drug Saf. 2019 May;28(5):593-600. doi: 10.1002/pds.4713. Epub 2019 Jan 16.

PMID:
30648314
19.

Efficacy and safety of 12 weeks of daclatasvir, asunaprevir plus ribavirin for HCV genotype-1b infection without NS5A resistance-associated substitutions.

Yu ML, Hung CH, Huang YH, Peng CY, Lin CY, Cheng PN, Chien RN, Hsu SJ, Liu CH, Huang CF, Su CW, Huang JF, Liu CJ, Kao JH, Chuang WL, Chen PJ, Chen DS.

J Formos Med Assoc. 2019 Feb;118(2):556-564. doi: 10.1016/j.jfma.2018.11.007. Epub 2018 Dec 5.

20.

Taiwan consensus statement on the management of chronic hepatitis B.

Chien RN, Kao JH, Peng CY, Chen CH, Liu CJ, Huang YH, Hu TH, Yang HI, Lu SN, Ni YH, Chuang WL, Lee CM, Wu JC, Chen PJ, Liaw YF.

J Formos Med Assoc. 2019 Jan;118(1 Pt 1):7-38. doi: 10.1016/j.jfma.2018.11.008. Epub 2018 Dec 6.

21.

Multiple doses of hepatitis B recombinant vaccine for chronic hepatitis B patients with low surface antigen levels: a pilot study.

Lai MW, Hsu CW, Lin CL, Chien RN, Lin WR, Chang CS, Liang KH, Yeh CT.

Hepatol Int. 2018 Sep;12(5):456-464. doi: 10.1007/s12072-018-9890-x. Epub 2018 Aug 7.

PMID:
30088198
22.

A community-based study on the association between Helicobacter pylori Infection and obesity.

Chen LW, Kuo SF, Chen CH, Chien CH, Lin CL, Chien RN.

Sci Rep. 2018 Jul 16;8(1):10746. doi: 10.1038/s41598-018-28792-1.

23.

Reply to "letter to the editor"-combination therapy for chronic hepatitis B: The future and beyond.

Hsu CW, Chien RN, Liaw YF.

J Formos Med Assoc. 2018 Aug;117(8):747-748. doi: 10.1016/j.jfma.2018.05.022. Epub 2018 Jun 19. No abstract available.

24.

A novel risk score for hepatocellular carcinoma in Asian cirrhotic patients: a multicentre prospective cohort study.

Liang KH, Ahn SH, Lee HW, Huang YH, Chien RN, Hu TH, Lin KH, Yeh CS, Hsu CW, Lin CL, Pan TL, Ke PY, Chang ML, Yeh CT.

Sci Rep. 2018 Jun 5;8(1):8608. doi: 10.1038/s41598-018-26992-3.

25.

Simple score to predict risk of hepatocellular carcinoma in chronic hepatitis C patients with advanced fibrosis after pegylated interferon and ribavirin therapy.

Hu CC, Weng CH, Chang LC, Lin CL, Chen YT, Hu CF, Hua MC, Chen LW, Chien RN.

Ther Clin Risk Manag. 2018 Apr 30;14:783-791. doi: 10.2147/TCRM.S158424. eCollection 2018.

26.

Phase IV randomized clinical study: Peginterferon alfa-2a with adefovir or entecavir pre-therapy for HBeAg-positive chronic hepatitis B.

Hsu CW, Su WW, Lee CM, Peng CY, Chuang WL, Kao JH, Chu HC, Huang YH, Chien RN, Liaw YF.

J Formos Med Assoc. 2018 Jul;117(7):588-597. doi: 10.1016/j.jfma.2017.12.007. Epub 2018 Feb 16.

27.

Development of a fibrosis index including hepatitis B virus basal core promoter A1762T mutation for pretherapeutic evaluation.

Yeh CS, Hsu CW, Liang KH, Chen YC, Lin CL, Chien RN, Hu TH, Lin WR, Lai MW, Chu YD, Yeh CT.

J Gastroenterol Hepatol. 2018 Aug;33(8):1530-1537. doi: 10.1111/jgh.14120. Epub 2018 Mar 12.

PMID:
29424069
28.

Association between metabolic syndrome and bone fracture risk: A community-based study using a fracture risk assessment tool.

Yu CY, Chen FP, Chen LW, Kuo SF, Chien RN.

Medicine (Baltimore). 2017 Dec;96(50):e9180. doi: 10.1097/MD.0000000000009180.

29.

Efficacy of Ledipasvir and Sofosbuvir Treatment of HCV Infection in Patients Coinfected With HBV.

Liu CJ, Chuang WL, Sheen IS, Wang HY, Chen CY, Tseng KC, Chang TT, Massetto B, Yang JC, Yun C, Knox SJ, Osinusi A, Camus G, Jiang D, Brainard DM, McHutchison JG, Hu TH, Hsu YC, Lo GH, Chu CJ, Chen JJ, Peng CY, Chien RN, Chen PJ.

Gastroenterology. 2018 Mar;154(4):989-997. doi: 10.1053/j.gastro.2017.11.011. Epub 2017 Nov 22.

PMID:
29174546
30.

Memory Regulatory T cells Increase Only In Inflammatory Phase of Chronic Hepatitis B Infection and Related to Galectin-9/Tim-3 interaction.

Hu CC, Jeng WJ, Chen YC, Fang JH, Huang CH, Teng W, Hsieh YC, Lin YC, Chien RN, Sheen IS, Lin CY.

Sci Rep. 2017 Nov 10;7(1):15280. doi: 10.1038/s41598-017-15527-x.

31.

Incidence and predictors of hepatitis B surface antigen seroclearance after cessation of nucleos(t)ide analogue therapy in hepatitis B e antigen-negative chronic hepatitis B.

Jeng WJ, Chen YC, Chien RN, Sheen IS, Liaw YF.

Hepatology. 2018 Aug;68(2):425-434. doi: 10.1002/hep.29640. Epub 2018 May 6.

PMID:
29108132
32.

Strategies to manage hepatitis C virus infection disease burden-Volume 4.

Chen DS, Hamoudi W, Mustapha B, Layden J, Nersesov A, Reic T, Garcia V, Rios C, Mateva L, Njoya O, Al-Busafi SA, Abdelmageed MK, Abdulla M, Adda D, Akin O, Al Baqali A, Al Dweik N, Al Ejji K, Al Ghazzawi I, Al Kaabi S, Al Naamani K, Al Qamish J, Al Sadadi M, Al Salman J, AlBadri M, Al-Romaihi HE, Ampofo W, Antonov K, Anyaike C, Arome F, Bane A, Blach S, Borodo MM, Brandon SM, Bright B, Butt MT, Cardenas I, Chan HLY, Chen CJ, Chen PJ, Chien RN, Chuang WL, Cuellar D, Derbala M, Elbardiny AA, Estes C, Farag E, Fung J, Gamkrelidze I, Genov J, Ghandour Z, Ghuloom M, Gomez B, Gunter J, Habeeb J, Hajelssedig O, Himatt SM, Hrstic I, Hu CC, Huang CF, Hui YT, Jahis R, Jelev D, John AK, Kaliaskarova KS, Kamel Y, Kao JH, Khamis J, Khattabi H, Khoudri I, Konysbekova A, Kotzev I, Lai MS, Lao WC, Lee MH, Lesi O, Li M, Lo A, Loo CK, Lukšić B, Maaroufi A, Malu AO, Mitova R, Mohamed R, Morović M, Murphy K, Nde H, Ngige E, Njouom R, Nonković D, Obekpa S, Oguche S, Okolo EE, Omede O, Omuemu C, Ondoa P, Opare-Sem O, Owusu-Ofori S, Phillips RO, Prokopenko YN, Razavi H, Razavi-Shearer D, Razavi-Shearer K, Redae B, Rinke de Wit T, Robbins S, Roberts LR, Sanad SJ, Sharma M, Simonova M, Su TH, Sultan K, Tan SS, Tchernev K, Tsang OTY, Tsang S, Tzeuton C, Ugoeze S, Uzochukwu B, Vi R, Vince A, Wani HU, Wong VWS, Workneh A, Yacoub R, Yesmembetov KI, Youbi M, Yuen MF, Schmelzer JD.

J Viral Hepat. 2017 Oct;24 Suppl 2:44-63. doi: 10.1111/jvh.12759.

PMID:
29105286
33.

Historical epidemiology of hepatitis C virus in select countries-volume 4.

Maaroufi A, Vince A, Himatt SM, Mohamed R, Fung J, Opare-Sem O, Workneh A, Njouom R, Al Ghazzawi I, Abdulla M, Kaliaskarova KS, Owusu-Ofori S, Abdelmageed MK, Adda D, Akin O, Al Baqali A, Al Dweik N, Al Ejji K, Al Kaabi S, Al Naamani K, Al Qamish J, Al Sadadi M, Al Salman J, AlBadri M, Al-Busafi SA, Al-Romaihi HE, Ampofo W, Antonov K, Anyaike C, Arome F, Bane A, Blach S, Borodo MM, Brandon SM, Bright B, Butt MT, Cardenas I, Chan HLY, Chen CJ, Chen DS, Chen PJ, Chien RN, Chuang WL, Cuellar D, Derbala M, Elbardiny AA, Estes C, Farag E, Gamkrelidze I, Garcia V, Genov J, Ghandour Z, Ghuloom M, Gomez B, Gunter J, Habeeb J, Hajelssedig O, Hamoudi W, Hrstic I, Hu CC, Huang CF, Hui YT, Jahis R, Jelev D, John AK, Kamel Y, Kao JH, Khamis J, Khattabi H, Khoudri I, Konysbekova A, Kotzev I, Lai MS, Lao WC, Layden J, Lee MH, Lesi O, Li M, Lo A, Loo CK, Lukšić B, Malu AO, Mateva L, Mitova R, Morović M, Murphy K, Mustapha B, Nde H, Nersesov A, Ngige E, Njoya O, Nonković D, Obekpa S, Oguche S, Okolo EE, Omede O, Omuemu C, Ondoa P, Phillips RO, Prokopenko YN, Razavi H, Razavi-Shearer D, Redae B, Reic T, Rinke de Wit T, Rios C, Robbins S, Roberts LR, Sanad SJ, Schmelzer JD, Sharma M, Simonova M, Su TH, Sultan K, Tan SS, Tchernev K, Tsang OTY, Tsang S, Tzeuton C, Ugoeze S, Uzochukwu B, Vi R, Wani HU, Wong VWS, Yacoub R, Yesmembetov KI, Youbi M, Yuen MF, Razavi-Shearer K.

J Viral Hepat. 2017 Oct;24 Suppl 2:8-24. doi: 10.1111/jvh.12762. Review.

PMID:
29105285
34.

The present and future disease burden of hepatitis C virus infections with today's treatment paradigm: Volume 4.

Chan HLY, Chen CJ, Omede O, Al Qamish J, Al Naamani K, Bane A, Tan SS, Simonova M, Cardenas I, Derbala M, Akin O, Phillips RO, Abdelmageed MK, Abdulla M, Adda D, Al Baqali A, Al Dweik N, Al Ejji K, Al Ghazzawi I, Al Kaabi S, Al Sadadi M, Al Salman J, AlBadri M, Al-Busafi SA, Al-Romaihi HE, Ampofo W, Antonov K, Anyaike C, Arome F, Blach S, Borodo MM, Brandon SM, Bright B, Butt MT, Chen DS, Chen PJ, Chien RN, Chuang WL, Cuellar D, Elbardiny AA, Estes C, Farag E, Fung J, Gamkrelidze I, Garcia V, Genov J, Ghandour Z, Ghuloom M, Gomez B, Gunter J, Habeeb J, Hajelssedig O, Hamoudi W, Himatt SM, Hrstic I, Hu CC, Huang CF, Hui YT, Jahis R, Jelev D, John AK, Kaliaskarova KS, Kamel Y, Kao JH, Khamis J, Khattabi H, Khoudri I, Konysbekova A, Kotzev I, Lai MS, Lao WC, Layden J, Lee MH, Lesi O, Li M, Lo A, Loo CK, Lukšić B, Maaroufi A, Malu AO, Mateva L, Mitova R, Mohamed R, Morović M, Murphy K, Mustapha B, Nersesov A, Ngige E, Njouom R, Njoya O, Nonković D, Obekpa S, Oguche S, Okolo EE, Omuemu C, Ondoa P, Opare-Sem O, Owusu-Ofori S, Prokopenko YN, Razavi H, Razavi-Shearer D, Razavi-Shearer K, Redae B, Reic T, Rinke de Wit T, Rios C, Robbins S, Roberts LR, Sanad SJ, Schmelzer JD, Sharma M, Su TH, Sultan K, Tchernev K, Tsang OTY, Tsang S, Tzeuton C, Ugoeze S, Uzochukwu B, Vi R, Vince A, Wani HU, Wong VWS, Workneh A, Yacoub R, Yesmembetov KI, Youbi M, Yuen MF, Nde H.

J Viral Hepat. 2017 Oct;24 Suppl 2:25-43. doi: 10.1111/jvh.12760.

PMID:
29105283
35.

Unawareness of Hepatitis B Virus Infection confers on Higher Rate of Metabolic Syndrome: A Community-based Study.

Chien CH, Chen LW, Lin CL, Chang SW, Shyu YC, Chen KF, Chen SW, Hu CC, Yu CY, Chien RN.

Sci Rep. 2017 Aug 29;7(1):9869. doi: 10.1038/s41598-017-10029-2.

36.

Body mass index above 24 is beneficial for the 6-month survival rate in hepatocellular carcinoma patients with extrahepatic metastases.

Chang YS, Huang JS, Yen CL, Chien RN, Wang CH, Lai CH, Wu TH, Lan YJ, Yeh KY.

Asia Pac J Clin Nutr. 2017;26(4):637-641. doi: 10.6133/apjcn.062016.03.

37.

Intrahepatic HCV RNA Level and Genotype 1 Independently Associate with Hepatic Reticulon 3 Expression.

Lin CL, Chien RN, Liang KH, Ke PY, Huang YH, Yeh CT.

Anticancer Res. 2017 Jun;37(6):2885-2891.

PMID:
28551625
38.

Favorable Response to Long-term Nucleos(t)ide Analogue Therapy in HBeAg-positive Patients with High Serum Fucosyl-Agalactosyl IgG.

Ho CH, Tsai HW, Lee CY, Huang LJ, Chien RN, Wu IC, Chiu YC, Liu WC, Cheng PN, Chang TT, Chen SH.

Sci Rep. 2017 May 16;7(1):1957. doi: 10.1038/s41598-017-02158-5.

39.
40.

Association between Parathyroid Hormone, 25 (OH) Vitamin D, and Chronic Kidney Disease: A Population-Based Study.

Wang WH, Chen LW, Lee CC, Sun CY, Shyu YC, Hsu HR, Chien RN, Wu IW.

Biomed Res Int. 2017;2017:7435657. doi: 10.1155/2017/7435657. Epub 2017 Mar 7.

41.

A Circulating MicroRNA Signature Capable of Assessing the Risk of Hepatocellular Carcinoma in Cirrhotic Patients.

Huang YH, Liang KH, Chien RN, Hu TH, Lin KH, Hsu CW, Lin CL, Pan TL, Ke PY, Yeh CT.

Sci Rep. 2017 Mar 31;7(1):523. doi: 10.1038/s41598-017-00631-9.

42.

Analyzing the influence of gastric intestinal metaplasia on gastric ulcer healing in Helicobacter pylori-infected patients without atrophic gastritis.

Chen LW, Chang LC, Hua CC, Hsieh BJ, Chen SW, Chien RN.

BMC Gastroenterol. 2017 Jan 3;17(1):1. doi: 10.1186/s12876-016-0563-8.

43.

Urgency to treat patients with chronic hepatitis C in Asia.

Kao JH, Ahn SH, Chien RN, Cho M, Chuang WL, Jeong SH, Liu CH, Paik SW.

J Gastroenterol Hepatol. 2017 May;32(5):966-974. doi: 10.1111/jgh.13709. Review.

PMID:
28005275
44.

Diabetes, hepatocellular carcinoma, and mortality in hepatitis C-infected patients: A population-based cohort study.

Huang TS, Lin CL, Lu MJ, Yeh CT, Liang KH, Sun CC, Shyu YC, Chien RN.

J Gastroenterol Hepatol. 2017 Jul;32(7):1355-1362. doi: 10.1111/jgh.13670.

PMID:
27930829
45.

Treatment-emergent depression and anxiety between peginterferon alpha-2a versus alpha-2b plus ribavirin for chronic hepatitis C.

Wang LJ, Chen SW, Chen CK, Yen CL, Chang JJ, Lee TS, Liu CJ, Chen LW, Chien RN.

BMC Psychiatry. 2016 Nov 25;16(1):424.

46.

Clinical Relapse After Cessation of Tenofovir Therapy in Hepatitis B e Antigen-Negative Patients.

Jeng WJ, Chen YC, Sheen IS, Lin CL, Hu TH, Chien RN, Liaw YF.

Clin Gastroenterol Hepatol. 2016 Dec;14(12):1813-1820.e1. doi: 10.1016/j.cgh.2016.07.002. Epub 2016 Jul 9.

PMID:
27404969
47.

UGT2B28 genomic variation is associated with hepatitis B e-antigen seroconversion in response to antiviral therapy.

Liang KH, Lin CL, Hsu CW, Lai MW, Chien RN, Yeh CT.

Sci Rep. 2016 Sep 26;6:34088. doi: 10.1038/srep34088.

48.

Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients.

Su TH, Hu TH, Chen CY, Huang YH, Chuang WL, Lin CC, Wang CC, Su WW, Chen MY, Peng CY, Chien RN, Huang YW, Wang HY, Lin CL, Yang SS, Chen TM, Mo LR, Hsu SJ, Tseng KC, Hsieh TY, Suk FM, Hu CT, Bair MJ, Liang CC, Lei YC, Tseng TC, Chen CL, Kao JH; C-TEAM study group and the Taiwan Liver Diseases Consortium.

Liver Int. 2016 Dec;36(12):1755-1764. doi: 10.1111/liv.13253. Epub 2016 Oct 4.

PMID:
27634134
49.

Transient Elastography for Spleen Stiffness Measurement in Patients With Cirrhosis: Role in Degree of Thrombocytopenia.

Chien CH, Lin YL, Chien RN, Hu CC, Yen CL, Lee TS, Hsieh PJ, Lin CL.

J Ultrasound Med. 2016 Sep;35(9):1849-57. doi: 10.7863/ultra.15.09064. Epub 2016 Jul 1.

PMID:
27371373
50.

miR-122-mediated translational repression of PEG10 and its suppression in human hepatocellular carcinoma.

Shyu YC, Lee TL, Lu MJ, Chen JR, Chien RN, Chen HY, Lin JF, Tsou AP, Chen YH, Hsieh CW, Huang TS.

J Transl Med. 2016 Jul 2;14(1):200. doi: 10.1186/s12967-016-0956-z.

Supplemental Content

Loading ...
Support Center